Subscribe

Q & M Dental Group (Singapore) Limited (QC7.SI)

SGD0.54 -0.01 (-0.92%)
SG SES Healthcare Medical - Care Facilities
Address No. 04-01 Logis Hub @ Clementi 129809
Singapore, SG
CEO Chin-Siau Ng
Website qandm.com.sg
IPO 2009-11-26
ISIN SG2E73981531

Explore sections of this company profile

Description

Q & M Dental Group (Singapore) Limited, an investment holding firm, primarily delivers private dental healthcare services. The company's operations are divided into three main segments: Primary Healthcare, Dental Equipment and Supplies Distribution, and Medical Laboratory. It offers a comprehensive spectrum of dental services, encompassing general dentistry, aesthetic and cosmetic treatments, CAD CAM digital solutions, pediatric and geriatric dental care, and dental implants. Specific procedures include consultations, gum disease treatment and surgery, oral surgery, root canal therapy, scaling and polishing, teeth grinding solutions, whitening procedures, tooth-colored fillings, wisdom tooth extractions, crowns and bridges, dental X-rays, dentures, extractions, mouth guards, orthodontics, and sensitive teeth care. Beyond its dental offerings, the group provides extensive general health services. These comprise adult and children consultations, chronic disease management, men's health, and skin care services. Preventative care includes cervical PAP smears, family planning, general and pre-marital health screenings, smoking cessation programs, and weight loss management. Vaccinations for conditions such as cervical cancer, chickenpox, childhood diseases, hepatitis, and influenza are available, along with travel health advice. Additional services extend to pre-education/extracurricular activity certifications, pre-employment checks, ear syringing, removal of foreign materials and warts, suturing, and wound care and dressing. The company further engages in swabbing, pre-departure and pre-event testing, and general laboratory testing services, as well as selling test kits. It also contributes to professional development by offering higher education programs for dentists, trades in dental surgery materials and equipment, and develops dental healthcare software and specialized equipment. As of December 31, 2021, Q & M Dental Group operated a significant network, including 97 dental clinics, 5 medical clinics, and 1 dental college in Singapore. Its international footprint extended to 38 dental clinics in Malaysia and one dental clinic in the People's Republic of China. Founded in 1996, the company is headquartered in Singapore and functions as a subsidiary of Quan Min Holdings Pte. Ltd.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SGD0.54 -0.01 (-0.92%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.81
Float Shares
342.96M
Free Float %
36.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+5.83% +6.72% +8.55% +20.95% +25.74% +15.45% +81.43% +118.97% +12.06% +5.10% +456.38%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.54
DCF (Unlevered) 0.90 +65.8%
DCF (Levered) 0.73 +35.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 67% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 -1
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.00
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +9.2% Q2'25: -0.5% (vs Q2'24)
  • ✗
    EPS growth Medical - Care Facilities: +19.2%
    -36.8% Q2'25: -61.5% (vs Q2'24)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +19.9% ★ Q2'25: +15.2% (vs Q2'24)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +18.7% ★ Q2'25: +13.1% (vs Q2'24)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +14.5% ★ Q2'25: +9.3% (vs Q2'24)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    -0.1% ★ Q2'25: +0.2% (vs Q2'24)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    3.33× Q2'25: 6.75× (vs Q2'24)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.78) × ERP
WACC = 76% × Ke + 24% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 0.90 Current price: 0.54
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
3 Rev. Ana.
2 EPS Ana. 		Dec 2027
3 Rev. Ana.
2 EPS Ana. 		Dec 2028
3 Rev. Ana.
3 EPS Ana.
Revenue
124.00M
est: 132.55M (-6.5%)
154.94M
est: 149.17M (+3.9%)
123.49M
est: 124.50M (-0.8%)
119.89M
est: 120.20M (-0.3%)
127.96M
est: 131.50M (-2.7%)
137.62M
est: 134.95M (+2.0%)
205.60M
est: 208.47M (-1.4%)
181.21M
est: 179.69M (+0.8%)
182.72M
est: 184.37M (-0.9%)
180.67M
est: 186.15M (-2.9%)
197.23M
est: 187.19M (+5.4%)
211.83M
202.30M – 220.00M
+13.2% YoY
222.57M
208.90M – 235.10M
+5.1% YoY
233.17M
233.17M – 233.17M
+4.8% YoY
EBITDA
20.78M
est: 31.64M (-34.3%)
26.69M
est: 35.60M (-25.0%)
30.91M
est: 29.72M (+4.0%)
15.94M
est: 28.69M (-44.4%)
39.26M
est: 31.39M (+25.1%)
37.80M
est: 32.21M (+17.3%)
63.72M
est: 49.76M (+28.1%)
35.25M
est: 42.89M (-17.8%)
37.18M
est: 44.47M (-16.4%)
38.10M
est: 44.90M (-15.1%)
56.67M
est: 45.15M (+25.5%)
51.10M
48.80M – 53.07M
+13.2% YoY
53.69M
50.39M – 56.71M
+5.1% YoY
56.24M
56.24M – 56.24M
+4.8% YoY
EBIT
19.59M
est: 19.95M (-1.8%)
22.23M
est: 22.46M (-1.0%)
27.66M
est: 18.74M (+47.6%)
12.63M
est: 18.09M (-30.2%)
24.53M
est: 19.80M (+23.9%)
26.27M
est: 20.31M (+29.3%)
50.14M
est: 31.38M (+59.8%)
18.19M
est: 27.05M (-32.8%)
19.32M
est: 27.62M (-30.1%)
20.12M
est: 27.89M (-27.8%)
36.95M
est: 28.05M (+31.7%)
31.74M
30.31M – 32.96M
+13.2% YoY
33.35M
31.30M – 35.22M
+5.1% YoY
34.94M
34.94M – 34.94M
+4.8% YoY
Net Income
11.40M
est: 11.45M (-0.4%)
28.30M
est: 14.42M (+96.3%)
23.87M
est: 14.21M (+68.0%)
14.01M
est: 15.79M (-11.3%)
17.98M
est: 12.63M (+42.4%)
19.70M
est: 15.08M (+30.7%)
30.47M
est: 32.66M (-6.7%)
11.31M
est: 17.92M (-36.9%)
11.52M
est: 15.98M (-27.9%)
14.64M
est: 17.07M (-14.3%)
9.31M
est: 20.78M (-55.2%)
13.44M
12.04M – 13.74M
-35.3% YoY
13.52M
12.63M – 14.41M
+0.6% YoY
14.20M
12.30M – 16.09M
+5.0% YoY
SGA
20.75M
est: 23.14M (-10.3%)
1.12M
est: 26.05M (-95.7%)
2.35M
est: 21.74M (-89.2%)
20.06M
est: 20.99M (-4.4%)
10.95M
est: 22.96M (-52.3%)
7.37M
est: 23.56M (-68.7%)
11.79M
est: 36.40M (-67.6%)
274.0K
est: 31.38M (-99.1%)
1.48M
est: 51.71M (-97.1%)
135.97M
est: 52.21M (+160.4%)
114.96M
est: 52.50M (+119.0%)
59.42M
56.74M – 61.71M
+13.2% YoY
62.43M
58.59M – 65.94M
+5.1% YoY
65.40M
65.40M – 65.40M
+4.8% YoY
EPS
0.01
est: 0.01 (+1.0%)
0.03
est: 0.02 (+95.1%)
0.03
est: 0.02 (+66.7%)
0.01
est: 0.02 (-11.2%)
0.02
est: 0.01 (+43.3%)
0.02
est: 0.02 (+9.3%)
0.03
est: 0.03 (-6.3%)
0.01
est: 0.02 (-35.8%)
0.01
est: 0.02 (-27.8%)
0.02
est: 0.02 (-14.4%)
0.01
est: 0.02 (-55.0%)
0.01
0.01 – 0.01
-37.3% YoY
0.01
0.01 – 0.02
+4.9% YoY
0.02
0.01 – 0.02
+9.3% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-28 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-26 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-25 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-22 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-21 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
28.58M
OE per share TTM
0.03
Owner's Yield
4.75%
Maintenance CapEx ratio
46.05%
Maint CapEx / Avg PPE
47.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 4 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Dimensional - International Small Cap ETF DFIS 0.00% 69.6K 0.39%
2 Dimensional World ex U.S. Core Equity 2 ETF DFAX 0.00% 48.9K 0.28%
3 Dimensional - International Core Equity 2 ETF DFIC 0.00% 14.8K 0.22%
4 Dimensional International Sustainability Core 1 ETF DFSI 0.00% — 0.24%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
76.2K
Shares Outstanding
947.04M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Chin-Siau Ng Founder, Group Chief Executive Officer & Non-Independent Executive Director 888.8K —
Ee Peng Ang Chief Operating Officer & Alternate Director 388.5K —
Madam Siew Jiuan Foo General Manager — —
Madam Sook Hwa Ng Chief Financial Officer — —
Shan Tong Company Secretary — female
Yun Siew Teh Legal Counsel — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities